WHI clinical trial revisit: Imprecise scientific methodology disqualifies the study's outcomes

American Journal of Obstetrics and Gynecology

Volumn 193, Issue 5, 2005, Pages 1599-1604

  Ostrzenski, Adam ^a,b,d   Ostrzenska, Katarzyna M ^c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Institute of Gynecology Inc   (United States)

^c Bayfront Med Center St Petersburg   (United States)

^d Bayfront Medical Center ^*  (United States)

Author keywords

Estrogen replacement therapy; Hormone replacement therapy; Menopause; Prempro; Women's Health Initiative Study

Indexed keywords

ACETYLSALICYLIC ACID; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO;

AGE DISTRIBUTION; ANAMNESIS; ARTICLE; BREAST CARCINOMA; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; COLON CARCINOMA; COLORECTAL CARCINOMA; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DIET SUPPLEMENTATION; DOSE RESPONSE; ETHNOLOGY; EVIDENCE BASED MEDICINE; FAMILIAL CANCER; FEMALE; FRACTURE; HEALTH STATUS; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LOW FAT DIET; MEDICAL PROFESSION; MENOPAUSAL SYNDROME; POSTMENOPAUSE; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH; QUALITY CONTROL; QUESTIONNAIRE; SCREENING; STROKE; TABLET;

AGED; DRUG COMBINATIONS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 27544482963     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.07.085     Document Type: Article

References (6)

1. Writing Group for the Women's Health Initiative Investigators Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial JAMA 288 2002 321 333
2. S.W. Fletcher, and G.A. Colditz Failure of estrogen plus progestin therapy for prevention JAMA 288 2002 366 386
3. The Women's Health Initiative Study Group Design of Women's Health Initiative clinical trial and observational study Control Clin Trials 19 1998 61 109
4. American College of Obstetricians and Gynecologists. HRT recommendation for physicians. ACOG, Washington, DC, August 9, 2002.
5. American College of Obstetricians and Gynecologists. HRT recommendation for women. ACOG, Washington, DC, August 9, 2002.
6. J.L. Stanford, P. Hartge, L.A. Brinton, R.N. Hoover, and R. Brookmeyer Factors influencing the age at natural menopause J Chronic Dis 40 1987 995 1002